Christoph Bruening
Corporate Officer/Principal chez Value Relations GmbH
Postes actifs de Christoph Bruening
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Value Relations GmbH | Corporate Officer/Principal | 01/01/1999 | - |
Historique de carrière de Christoph Bruening
Anciens postes connus de Christoph Bruening
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/05/2003 | 26/05/2010 |
Statistiques
Internationale
| Etats-Unis | 2 |
| Allemagne | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Value Relations GmbH |
- Bourse
- Insiders
- Christoph Bruening
- Expérience
